128 related articles for article (PubMed ID: 33403820)
21. Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.
Ray AM; Zuhlke KA; Johnson GR; Levin AM; Douglas JA; Lange EM; Cooney KA
Br J Cancer; 2009 Dec; 101(12):2043-7. PubMed ID: 19935797
[TBL] [Abstract][Full Text] [Related]
22. Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion.
Rizeq B; Sif S; Nasrallah GK; Ouhtit A
J Cell Mol Med; 2020 Oct; 24(19):11477-11488. PubMed ID: 32888398
[TBL] [Abstract][Full Text] [Related]
23. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
[TBL] [Abstract][Full Text] [Related]
24. Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis.
Wang R; Zhang J; Cui X; Wang S; Chen T; Niu Y; Du X; Kong J; Wang L; Jiang Y
World J Surg Oncol; 2023 Mar; 21(1):91. PubMed ID: 36907870
[TBL] [Abstract][Full Text] [Related]
25. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.
Kote-Jarai Z; Jugurnauth S; Mulholland S; Leongamornlert DA; Guy M; Edwards S; Tymrakiewitcz M; O'Brien L; Hall A; Wilkinson R; Al Olama AA; Morrison J; Muir K; Neal D; Donovan J; Hamdy F; Easton DF; Eeles R; ;
Br J Cancer; 2009 Jan; 100(2):426-30. PubMed ID: 19127258
[TBL] [Abstract][Full Text] [Related]
26. Four common polymorphisms of BRIP1 (rs2048718, rs4988344, rs4986764, and rs6504074) and cancer risk: evidence from 13,716 cancer patients and 15,590 cancer-free controls.
Liu D; Zheng Y; Wang M; Deng Y; Lin S; Zhou L; Yang P; Dai C; Xu P; Hao Q; Song D; Kang H; Dai Z
Aging (Albany NY); 2018 Feb; 10(2):266-277. PubMed ID: 29466248
[TBL] [Abstract][Full Text] [Related]
27. Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control study.
Flaum N; van Veen EM; Smith O; Amico S; Newman WG; Crosbie EJ; Edmondson R; Smith MJ; Evans DG
Clin Genet; 2022 Jan; 101(1):48-54. PubMed ID: 34585738
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
Vysotskaia V; Kaseniit KE; Bucheit L; Ready K; Price K; Johansen Taber K
Cancer; 2020 Feb; 126(3):549-558. PubMed ID: 31682005
[TBL] [Abstract][Full Text] [Related]
29. New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer.
Castillo-Guardiola V; Sarabia-Meseguer MD; Marín-Vera M; Sánchez-Bermúdez AI; Alonso-Romero JL; Noguera-Velasco JA; Ruiz-Espejo F
Cancer Genet; 2018 Dec; 228-229():1-4. PubMed ID: 30553462
[TBL] [Abstract][Full Text] [Related]
30. Further evidence for the contribution of the BRCA1-interacting protein-terminal helicase 1 (BRIP1) gene in breast cancer susceptibility.
Ren LP; Xian YS; Diao DM; Chen Y; Guo Q; Dang CX
Genet Mol Res; 2013 Nov; 12(4):5793-801. PubMed ID: 24301948
[TBL] [Abstract][Full Text] [Related]
31. BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases.
Suszynska M; Ratajska M; Kozlowski P
J Ovarian Res; 2020 May; 13(1):50. PubMed ID: 32359370
[TBL] [Abstract][Full Text] [Related]
32. Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies.
Aloraifi F; McCartan D; McDevitt T; Green AJ; Bracken A; Geraghty J
Cancer Genet; 2015 Sep; 208(9):455-63. PubMed ID: 26250988
[TBL] [Abstract][Full Text] [Related]
33. Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.
Park JS; Lee ST; Nam EJ; Han JW; Lee JY; Kim J; Kim TI; Park HS
BMC Cancer; 2018 Jan; 18(1):83. PubMed ID: 29338689
[TBL] [Abstract][Full Text] [Related]
34. Ten genes for inherited breast cancer.
Walsh T; King MC
Cancer Cell; 2007 Feb; 11(2):103-5. PubMed ID: 17292821
[TBL] [Abstract][Full Text] [Related]
35. Mutations in BRIP1 confer high risk of ovarian cancer.
Rafnar T; Gudbjartsson DF; Sulem P; Jonasdottir A; Sigurdsson A; Jonasdottir A; Besenbacher S; Lundin P; Stacey SN; Gudmundsson J; Magnusson OT; le Roux L; Orlygsdottir G; Helgadottir HT; Johannsdottir H; Gylfason A; Tryggvadottir L; Jonasson JG; de Juan A; Ortega E; Ramon-Cajal JM; García-Prats MD; Mayordomo C; Panadero A; Rivera F; Aben KK; van Altena AM; Massuger LF; Aavikko M; Kujala PM; Staff S; Aaltonen LA; Olafsdottir K; Bjornsson J; Kong A; Salvarsdottir A; Saemundsson H; Olafsson K; Benediktsdottir KR; Gulcher J; Masson G; Kiemeney LA; Mayordomo JI; Thorsteinsdottir U; Stefansson K
Nat Genet; 2011 Oct; 43(11):1104-7. PubMed ID: 21964575
[TBL] [Abstract][Full Text] [Related]
36. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
37. Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis.
Pabalan N; Jarjanazi H; Ozcelik H
Breast Cancer Res Treat; 2013 Jan; 137(2):553-8. PubMed ID: 23225146
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
[TBL] [Abstract][Full Text] [Related]
39. BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature.
Ali M; Delozier CD; Chaudhary U
BMC Med Genet; 2019 May; 20(1):75. PubMed ID: 31064327
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic stem cell transplantation in FANCJ/BRIP1 fanconi anemia.
Alsultan A; Essa M; Alsudairy R
Bone Marrow Transplant; 2017 Mar; 52(3):463-465. PubMed ID: 27869810
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
